Results 61 to 70 of about 2,270 (175)

The Content of NO Metabolites in the Gastric Juice of Patients with Chronic Reflux Gastritis

open access: yesGastroenterologìa, 2014
To estimate the role of nitro compounds in pathogenesis of gastric mucosa lesion, the gastric juice concentrations of nitrites and nitrates have been investigated in 65 patients with chronic reflux gastritis.
A.N. Kovalenko
doaj   +1 more source

Correlation between serum gastrin and cellular proliferation in Barrett’s esophagus

open access: yesTherapeutic Advances in Gastroenterology, 2011
Background: Patients with Barrett’s esophagus (BE) are commonly treated with proton-pump inhibitors (PPIs) to minimize the exposure of esophageal mucosa to stomach acid.
Daniel A. Green   +6 more
doaj   +1 more source

Paradoxically Augmented Anti-Tumorigenic Action of Proton Pump Inhibitor and Gastrin in APCMin/+ Intestinal Polyposis Model1

open access: yesNeoplasia: An International Journal for Oncology Research, 2014
Though long-term administration of proton pump inhibitor (PPI) imposed the risk of gastrointestinal track tumorigenesis by accompanied hypergastrinemia, no overt increases of colon cancer risk were witnessed after a long-term cohort study.
Young-Min Han   +4 more
doaj   +1 more source

Experimental correction of pathological changes in salivary glands by multiprobiotic Symbiter® acidofilus under conditions of hypergastrinemia

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2010
Under conditions of long omeprazole introduction pathological changes in salivary glands tissues appear: intensification of free-radical oxidation, disbalance of proteolysis by decompensated type, increased activity of б-amilase, disbalance of ...
Andriy Sukhomlyn, Karine Neporada 
doaj  

Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies

open access: yesBMC Veterinary Research, 2017
Background Serum gastrin concentration can help diagnose gastrinomas in dogs if >3–10× the upper reference limit (URL), but antisecretory therapy and other conditions can also cause hypergastrinemia.
Romy M. Heilmann   +5 more
doaj   +1 more source

[Hypergastrinemia and type A gastritis in Basedow's disease].

open access: yesNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1992
Hypergastrinemia is a very important clinical condition for the reason that a growing body of evidence obtained from animal and human experiments has revealed gastric carcinoids induced by hypergastrinemia. We investigated 35 patients with Basedow's disease (BD) to elucidate the mechanism of hypergastrinemia associated with BD as well as the ...
KAISE, Mitsuru   +7 more
openaire   +2 more sources

Hashimoto's Thyroiditis and Entero-Chromaffin-like Cell Hyperplasia: Early Detection and Somatostatin Analogue Treatment

open access: yesEuropean Journal of Inflammation, 2013
Type IIIb polyglandular autoimmune disease comprises autoimmune thyroid disease (HT) and chronic atrophic gastritis (AIG). Hypergastrinemia, secondary to AIG, predisposes to gastric enterochromaffin-like cell (ECL) hyperplasia, a preneoplastic condition.
A. Renzullo   +12 more
doaj   +1 more source

The consequences of hypergastrinemia.

open access: yesThe Yale journal of biology and medicine, 1996
The only gastrin-dependent gastric endocrine cells are the fundic ECL cells. Excessive hypergastrinemia stimulates ECL cell proliferation in animals and man. The growth of other gastric endocrine cells is regulated by the gastric pH. Hypergastrinemia in man results in diffuse and linear hyperplasia of the ECL cells, while micronodular hyperplasia is ...
openaire   +1 more source

Modification of glycoconjugates signaling pathway duringesophageal barrier injury induced by experimental hypergastrinemia

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2009
The article presents lectinohistochemistry results of continuous 28 days’ trophicus influence of gastrin on the esophageal mucosa, induced by daily administration of omeprasol, the potent proton pump inhibitor.
Roman Pinyajko   +3 more
doaj  

Tumor carcinóide de estômago tipo 1

open access: yesRevista do Colégio Brasileiro de Cirurgiões
Gastric carcinoid occurs in less than 1% of gastric neoplasias and around 2% of carcinoids tumors. They are classified into three forms: type 1, associated with atrophic gastritis, type 2, associated with multiple endocrine neoplasia 1 and Zollinger ...
Rubens Valarini   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy